Antidote Health is a technology company.
Antidote Health has raised $41.0M across 3 funding rounds.
Antidote Health has raised $41.0M in total across 3 funding rounds.
Antidote Health has raised $41.0M in total across 3 funding rounds.
Antidote Health's investors include Flint Capital, Group 11, iAngels, Kli Capital, NFX, Welltech Ventures, Zeev Capital, Lior Ron, Moshe Yanai, Ronald Cohen.
Antidote Health is a virtual-first Health Maintenance Organization (HMO) that provides affordable ACA-compliant health insurance plans and AI-assisted telehealth services, targeting underserved communities across select U.S. states including Arizona, California, Florida, New York, Ohio, and Texas.[1][2][5] It serves individuals and small groups seeking accessible care without insurance barriers, solving high costs and limited access by offering $0 copays for virtual visits, mental health support, medications, and chronic condition management, while operating independently of traditional insurers to keep prices low.[1][2][5] The company has shown growth momentum through expansions like entering on-exchange markets in Ohio and Arizona for 2025, reaching 81% and 78% of those states' ACA populations respectively, and earning a Gold Merit Award in 2024 for integrating virtual care with insurance.[2][5]
Antidote Health was founded by a team with expertise in health, insurance, medicine, and technology, driven by frustration with the traditional healthcare model.[2] Co-founder and CEO Avihai Sodri has led key expansions, such as the recent on-exchange market entry.[5] The idea emerged from developing an AI-assisted telehealth service—offering one-time and subscription options—which laid the foundation for their full HMO insurance plans under the Affordable Care Act (ACA).[2] Early traction built on this virtual-first model, evolving to include small group plans and high-profile backing from investor and ambassador Giannis Antetokounmpo, fueling their mission to make quality care a basic human right.[2]
(Note: Search results distinguish Antidote Health from Antidote Technologies (antidote.me), a separate firm matching patients to clinical trials; this analysis focuses on Antidote Health as the queried technology company.[3][4])
Antidote Health rides the telehealth and virtual-first insurance wave, accelerated by post-pandemic demand for convenient, low-cost care amid rising U.S. healthcare expenses.[2][5] Timing aligns with ACA open enrollment expansions and regulatory shifts favoring digital HMOs, enabling market penetration in high-need states like Ohio and Arizona.[5] Favorable forces include AI-driven personalization, consumer shift from in-person to app-based services, and investor interest from figures like Giannis Antetokounmpo, positioning it to disrupt a $4 trillion industry fragmented by high deductibles and access gaps.[1][2] By influencing ecosystems through affordable models, it pushes competitors toward hybrid virtual-physical care, broadening equity for underserved populations.[1][5]
Antidote Health is poised for accelerated growth via further state expansions and ACA on-exchange scaling, potentially capturing more of the individual market with its $0 benefit edge.[5] Trends like AI telehealth advancements, mental health prioritization, and value-based care will shape its path, amplifying influence as a payvider model leader. Evolving from telehealth roots to a full HMO disruptor, it could redefine accessibility, tying back to its core fight for care as a human right in an increasingly digital health landscape.[1][2]
Antidote Health has raised $41.0M across 3 funding rounds. Most recently, it raised $7.0M Series A in May 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2023 | $7.0M Series A | Flint Capital, Group 11, iAngels, Kli Capital, NFX, Welltech Ventures, Zeev Capital, Lior Ron, Moshe Yanai, Ronald Cohen | |
| Mar 1, 2022 | $22.0M Series A | iAngels, Welltech Ventures, Moshe Yanai | |
| Aug 1, 2021 | $12.0M Seed | iAngels, Welltech Ventures, Moshe Yanai |